Embedded Files
Lu, Ching Chu
Office Address:
National Taiwan University Hospital
Department of Nuclear Medicine
No.7, Zhongshan S. Rd., Zhongzheng Dist.
Taipei City 100, Taiwan (R.O.C.)
kelvinlu@ntu.edu.tw
Education:
9/1997- 6/2004 M.D., College of Medicine, Taipei Medical University
9/2009-7/2011 M.Sc., Graduate Institute of Health Policy and Management, National Taiwan University
9/2014 - present Ph.D.,Graduate Institute of Epidemiology and Preventive Medicine
Training:
11/2005 - 7/2006 Resident, Emergency Medicine, Cheng Hsin General Hospital
8/2006 - 6/2008 Resident, Nuclear Medicine, National Taiwan University Hospital
7/2008 - 6/2009 Chief Resident, Nuclear Medicine, National Taiwan University Hospital
Board:
2004 M.D., License Registration
2008 Board of Nuclear Medicine
Membership of Academic Society:
2006 – present Society of Nuclear Medicine, Taiwan
2010 – present European Society of Nuclear Medicine
2013 – present Society of Medicine Cyclotron, Taiwan
Academic, Administrative, and Clinical Appointments:
Clinical
7/2009 - 11/2011 Attending Physician, Department of Nuclear Medicine, National Taiwan University Hospital, Yun Lin Branch
11/2011 - present Attending Physician, Department of Nuclear Medicine, National Taiwan University Hospital
Academic
8/2014 Lecturer, Division of Radiology, National Taiwan University
Administrative:
7/2009 - 11/2011 Director, Department of Nuclear Medicine, National Taiwan University Hospital, Yun Lin Branch
Publications:
1. Prognostic value of semiquantification NP-59 SPECT/CT in primary aldosteronism patients after adrenalectomy.
Lu CC, Wu VC, Wu KD, Liu KL, Lin WC, Cheng MF, Tzen KY, Yen RF; TAIPAI Study Group.
Eur J Nucl Med Mol Imaging. 2014 Jul;41(7):1375-84.
2. Combining body mass index and serum potassium to urine potassium clearance ratio is an alternative method to predict primary aldosteronism.
Kuo CC, Wu VC, Tsai CW, Huang KH, Wang SM, Li BC, Chang CC, Lu CC, Yang WS, Chao CT, Tsai IC, Lai CF, Lin WC, Wu MS, Lin YH, Lin CY, Chang HW, Wang WJ, Chiang WC, Kao TW, Chueh SC, Chu TS, Tsai TJ, Wu KD; TAIPAI Study Group.
ClinChimActa. 2011 Aug 17;412(17-18):1637-42.
3. Verification and evaluation of aldosteronism demographics in the Taiwan Primary Aldosteronism Investigation Group (TAIPAI Group).
Kuo CC, Wu VC, Huang KH, Wang SM, Chang CC, Lu CC, Yang WS, Tsai CW, Lai CF, Lee TY, Lin WC, Wu MS, Lin YH, Chu TS, Lin CY, Chang HW, Wang WJ, Kao TW, Chueh SC, Wu KD, Taipai Study Group.
J Renin Angiotensin Aldosterone Syst. 2011 Sep;12(3):348-57.
4. FDG PET/CT findings in purely cutaneous Rosai-Dorfman disease.
Huang JY, Lu CC, Hsiao CH, Tzen KY.
Clin Nucl Med. 2011 Apr;36(4):e13-5.
5. 131I-6beta-iodomethyl-19-norcholesterol SPECT/CT for primary aldosteronism patients with inconclusive adrenal venous sampling and CT results.
Yen RF, Wu VC, Liu KL, Cheng MF, Wu YW, Chueh SC, Lin WC, Wu KD, Tzen KY, Lu CC; TAIPAI Study Group.
J Nucl Med. 2009 Oct;50(10):1631-7.
Page updated
Google Sites
Report abuse